Brain
|
 |
Differentiate recurrent tumor from radiation necrosis and primary CNS lymphoma from toxoplasmosis. |
| Breast |
|
Identify involved axillary nodes and distant metastatic disease.
|
|
Exclude local recurrence of disease and evaluate response to treatment. |
| Cervical/Ovarian |
|
Detect recurrent/residual tumor. |
| Colorectal |
|
Detect locally recurrent and distant metastatic disease for preoperative evaluation.
|
| Esophageal |
|
Determine extent of primary tumor, detect recurrent/residual tumor, and stage metastatic disease.
|
| Head and Neck |
|
Diagnose and determine the extent of local, regional, and distant metastatic disease and evaluate response to therapy.
|
| Lung |
|
Identify malignant nodules, stage disease, and evaluate response to therapy.
|
| Lymphoma (Adult & Pediatric) |
|
Determine disease staging and measure treatment response.
|
| Melanoma |
|
Identify extent of local and regional disease spread.
|
| Musculoskeletal/Soft Tissue Sarcoma |
|
Evaluate local extent of disease, exclude distant metastases, and measure treatment response.
|
| Pancreatic |
|
Identify malignant disease or rule out distant metastases for preoperative evaluation.
|
| Testicular |
|
Detect and stage metastatic disease, and evaluate response to treatment.
|
| Thyroid |
|
Detect recurrence in patients with positive thyroglobulin levels and negative I-131 scans.
|
| Unknown Primary |
|
Evaluate rising tumor markers with no obvious radiological site.
|
|
Evaluate metastatic tumor found with no obvious primary site.
|
Patients
